Professor Eva Kaltenthaler BSc, BGSU (USA), MSc (London) PhD (London)

Professor of Health Technology Assessment

Kaltenthaler1

HEDS, ScHARR
University of Sheffield
Regent Court, 30 Regent Street
Sheffield, S1 4DA

Office: 112
ScHARR
West Court
Mappin Street
Sheffield
S1 4DP

Tel: (+44) (0)114 222 0810
Fax: (+44) (0)114 222 0749

E-mail: e.kaltenthaler@sheffield.ac.uk

ORCiD: 0000-0002-6185-8321

Biography

My methodological expertise is in the systematic reviewing of clinical effectiveness evidence and how this is used in decision making. I undertake systematic reviews for the National Institute for Health Research (NIHR). Health Technology Assessment Programme on behalf of a range of policy makers, including the National Institute for Health and Care Excellence (NICE). My work includes reviews on many topics such as: computerised cognitive behaviour therapy and sexual health interventions for people with severe mental illness.

I am Deputy Section Director of the Health Economics and Decision Science Section within ScHARR, Director of the ScHARR Equality and Diversity Committee and the Chair of the ScHARR Athena SWAN Self Assessment Group.

Research Interests

My research interests are:
• selecting rapid review methods
• the identification and review of estimates for cost effectiveness model parameters within health technology assessments
• methods used in the critical appraisal of manufacturers’ submissions within the NICE single technology appraisal process
• mental health technologies and therapies

Teaching Interests

I supervise Master's level dissertation students with a range of systematic review topics.

I supervise research students in areas such as systematic review methodology and issues around the reviewing of cost effectiveness model parameters.

I teach on a short course on The Identification and Review of Evidence to Inform Cost Effectiveness Models Link

Professional Activities

  • Member of the NICE Medical Technologies Advisory Committee

Current Projects

• NICE FTA Golimumab for Axial Spondyloarthritis
• NICE MTA Cabozatenib and vandetanib for Medullary Thyroid Cancer
• NIHR HTA TAR: The use of exploratory analyses within the National Institute for Health and Care Excellence single technology appraisal process: an evaluation and qualitative analysis
• NIHR Programme Grant: The design, development, commissioning and evaluation of patient focussed vascular services

Section

Eva Kaltenthaler is based in Health Economics and Decision Science (HEDS)

Health Economics and Decision Science

Extended List of Publications

Journal articles